Novartis AG (BVMF:N1VS34)

Market Cap	1.54T +29.7%
Revenue (ttm)	312.16B +9.6%
Net Income	77.02B +17.1%
EPS	39.38 +21.8%
Shares Out	n/a
PE Ratio	19.99
Forward PE	17.21
Dividend	1.42 (1.75%)
Ex-Dividend Date	Mar 11, 2025

Volume	17
Average Volume	142
Open	80.08
Previous Close	80.90
Day's Range	80.08 - 81.05
52-Week Range	59.42 - 85.13
Beta	0.45
RSI	59.36
Earnings Date	Feb 4, 2026

About Novartis AG

Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland, the United States, China, Germany, and internationally. It focuses on developing products in cardiovascular, renal and metabolic, immunology, neuroscience, oncology, and other therapeutic areas. The company offers Entresto, an angiotensin receptor-neprilysin inhibitor to treat symptomatic chronic heart failure with reduced ejection fraction (HFrEF); Cosentyx for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, a...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1996
• Employees: 75,883
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: N1VS34

Financial Performance

In 2025, Novartis AG's revenue was $56.67 billion, an increase of 9.57% compared to the previous year's $51.72 billion. Earnings were $13.98 billion, an increase of 17.11%.

Financial numbers in USD